Kolibri Global Energy Inc. Provides Update Regarding Information Circular Disclosure
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Kolibri Global Energy Inc. (the “Company” or “Kolibri“) (TSX:…
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving…
Golfers tee off for a great cause
Wednesday 17 September, 2025 Weston Turville Golf Club was buzzing with energy…
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by…
Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimers disease
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test…
Aon’s 2025 Global Cyber Risk Report Reveals Reputation Risk Events Can Reduce Shareholder Value by 27 percent
DUBLIN, June 17, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global…